Mouwasat Medical Services Co.’s second-quarter net profit (SAR 56.1 million) fell ten percent below Aljazira Capital’s estimate of SAR 62.7 million, the brokerage firm said in a report.
The investment arm of Bank AlJazira kept a “neutral” rating on the stock and set its target price at SAR 143.4.
The report also projected a 17 percent year-on-year rise in the hospital operator’s 2015 net profit, which is estimated to reach SAR 281.8 million.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}